GNP can be used as 'composite therapeutic agent' in clinical trials: Dr Harsh Vardhan
Jun 30, 2020
New Delhi [India], June 30 : Union Health Minister Dr Harsh Vardhan on Tuesday said that the Gold Nanoparticles synthesized by the National Centre for Polar and Ocean Research and Goa University can be used as a "composite therapeutic agent" in clinical trials for anti-cancer, anti-viral and anti-diabetic drugs.
In a series of tweets, the Union Health Minister spoke about the benefits of gold nanoparticles.
"The National Centre for Polar and Ocean Research (NCPOR) and @GoaUniversity (Goa University) have synthesized Gold Nanoparticles (GNPs). These GNPs can be used as a composite therapeutic agent in clinical trials, especially in anti-cancer, anti-viral and anti-diabetic drugs," the Minister tweeted.
"The study revealed the genotoxic effect of GNPs on a sulphate reducing bacteria (SRB). The GNPs display anti-bacterial properties by inhibiting SRB's growth & its sulphide production. Metallic NPs have biomedical applications & GNPs are effective in biomedical research," he added.
He further said that GNPs can be used for therapeutic imaging as well. "GNPs have unique optical properties too, & can be used for therapeutic imaging. GNPs also have unique physicochemical properties making them suitable for therapeutic applications including detection & diagnosis of diseases, bio-labelling and targeted drug delivery," he said.
